Galmed Pharmaceuticals (NASDAQ:GLMD) Coverage Initiated at StockNews.com

Equities research analysts at StockNews.com assumed coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Rating) in a note issued to investors on Saturday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Price Performance Shares of Galmed Pharmaceuticals stock opened at $3.60 on Friday. The business has a 50 day […]

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom , ,Raymond James Financial Services Advisors Inc ,Galmed Pharmaceuticals Ltd ,Galmed Pharmaceuticals ,News Ratings For Galmed Pharmaceuticals Daily ,Galmed Pharmaceuticals Price Performance ,Cambridge Investment Research Advisors Inc ,Institutional Trading Of Galmed Pharmaceuticals ,Millennium Management ,Get Rating ,James Financial Services Advisors ,Cambridge Investment Research Advisors ,Pharmaceuticals Ltd ,Galmed Pharmaceuticals Daily ,